Novartis Ag Income Statement (2009-2026) | NVS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	25.09B	0.23B	42.03B	0.26B	25.05B	0.24B	0.25B	0.32B	26.57B		22.23B		12.51B
Cost of Revenue (Quarter)	7.95B	0.24B	0.24B	0.29B	3.75B	0.24B	0.25B	0.33B	3.34B		6.33B		3.17B		6.27B		3.32B
Gross Profit (Quarter)	-0.01B	0.02B	0.01B	0.03B	-0.03B	0.00B	18.29B	5,000.00B	18.87B		16.46B		9.70B		18.72B		11.51B
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)	-2.40B	-0.22B	-0.24B	-0.21B	-4.82B	-0.19B	-0.23B	-0.22B	-2.30B		-4.88B		-2.37B		-4.79B		-2.73B
Selling, General & Administrative (Quarter)	-3.75B	-0.48B	-0.57B	-0.51B	-7.09B	-0.48B	-0.56B	-0.54B	-7.13B		-5.98B		-3.09B		-5.93B		-3.44B
Restructuring Costs (Quarter)
Operating Expenses (Quarter)	-6.15B	-0.70B	-0.81B	-0.72B	-11.91B	-0.67B	-0.79B	-0.76B	-9.43B		-10.86B		-5.46B		-10.72B		-6.17B
Operating Income (Quarter)	5.58B	0.44B	0.39B	0.39B	4.69B	0.38B	0.27B	0.32B	5.78B		5.42B		4.01B		7.39B		4.86B
EBIT (Quarter)	5.58B	0.44B	0.39B	0.39B	4.69B	0.38B	0.27B	0.32B	5.78B		5.42B		4.01B		7.39B		4.86B
Non-operating items
Non Operating Investment Income (Quarter)
Other Non Operating Income (Quarter)	-0.03B	-0.02B	-0.03B	0.02B	0.02B	-0.03B	0.02B	0.10B	0.09B	0.01B	0.02B	0.01B	0.07B	0.03B	0.03B	0.02B	-0.04B	-0.02B	-0.09B	-0.05B
Non Operating Income (Quarter)								0.10B				0.21B
Net income details
EBT (Quarter)	5.99B	0.64B	5.96B	0.59B	5.09B	0.58B	4.71B	0.52B	2.67B		5.19B		3.84B		6.97B		4.53B
Profit After Tax (Quarter)	5.99B	0.64B	4.95B	0.59B	5.09B	0.58B	3.91B	0.52B	2.32B		4.61B		3.25B		5.93B		4.02B
Income from Continuing Operations (Quarter)	5.99B	0.64B	5.96B	0.59B	5.09B	0.58B	4.71B	0.52B	2.67B		5.19B		3.84B		6.97B		4.53B
Consolidated Net Income (Quarter)	5.99B	0.64B	5.96B	0.59B	5.09B	0.24B	0.15B	0.14B	0.05B	0.25B	0.19B		3.84B		6.97B		4.53B
Income towards Parent Company (Quarter)	5.99B	0.64B	5.96B	0.59B	5.09B	0.24B	0.15B	0.14B	0.05B	0.25B	0.19B		3.84B		6.97B		4.53B
Net Income towards Common Stockholders (Quarter)	5.99B	0.64B	5.96B	0.59B	5.09B	0.24B	0.15B	0.14B	0.05B	0.25B	0.19B		3.84B		6.97B		4.53B
Additional items
EPS (Basic) (Quarter)	0.00	0.00	2.66	0.00	0.00B	113.43	0.07	141.18	0.00	88.03	0.23		0.00B		8.79		0.00
EPS (Weighted Average and Diluted) (Quarter)	0.00B	188.27	560.30	601.01	0.00B	114.49	54.91	142.57	42.20	88.34	46.34		0.00B		0.00B		0.00B
Shares Outstanding (Weighted Average) (Quarter)	2,243,000.00B	901,000.00B	2.23B	901,000.00B	0.00B	0.00B	2.12B	0.00B	842,000.00B	0.00B	0.82B	793,000.00B	0.00B	0.00B	0.79B	766,000.00B	766,000.00B	766,000.00B	766,000.00B	736,000.00B
Shares Outstanding (Diluted Average) (Quarter)	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.01B	0.01B	0.00B
EBITDA (Quarter)	5.58B	0.44B	0.39B	0.39B	4.69B	0.38B	0.27B	0.32B	5.78B		5.42B		4.01B		7.39B		4.86B
Interest Expenses (Quarter)	-0.40B	-0.20B	-0.21B	-0.20B	-0.40B	-0.21B	-0.21B	-0.20B	-0.22B	-0.22B	-0.22B	-0.22B	-0.25B	-0.26B	-0.28B	-0.27B	-0.29B	-0.28B	-0.30B	-0.34B

Research Tools

Novartis Ag Income Statement (2009-2026) | NVS

Create an account

Sign In

Reset Password